Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
| # | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|---|---|---|---|---|---|---|
| 451 | M1.PY.15.27 | 107046 |
Psychiatry
|
Child Abuse and Neglect |
M 3
|
D
|
| 452 | M1.GI.15.4669 | 107119 |
Gastrointestinal
|
Ulcerative Colitis |
M 1
|
D
|
| 453 | M1.BC.14.79 | 106905 |
Biochemistry
|
Glycolysis |
M 1
|
D
|
| 454 | M1.ON.12.41 | 101351 |
Oncology
|
Acute Lymphoblastic Leukemia (ALL) |
M 2
|
D
|
| 455 | M1.GI.15.7 | 104798 |
Gastrointestinal
|
Hepatitis |
M 2
|
D
|
| 456 | M1.MC.15.75 | 106711 |
Microbiology
|
Rubella Virus |
M 2
|
D
|
| 457 | M1.BC.15.72 | 106505 |
Biochemistry
|
Propionic Acid Pathway |
M 2
|
D
|
| 458 | M1.MC.15.74 | 106692 |
Microbiology
|
Neisseria gonorrhoeae |
M 1
|
D
|
| 459 | M1.RP.15.75 | 106838 |
Reproductive
|
Antiandrogens |
M 1
|
D
|
| 460 | M1.PY.15.16 | 102957 |
Psychiatry
|
Tourette Syndrome |
M 3
|
D
|
| 461 | M1.GI.15.22 | 104813 |
Gastrointestinal
|
Alpha-1 Antitrypsin Deficiency |
M 1
|
D
|
| 462 | M1.RL.13.63 | 101017 |
Renal
|
Loop Diuretics |
M 1
|
D
|
| 463 | M1.MC.15.74 | 106656 |
Microbiology
|
Vaccines |
M 1
|
D
|
| 464 | M1.MC.15.75 | 106869 |
Microbiology
|
Anti-Fungals |
M 1
|
D
|
| 465 | M1.NE.14.72 | 106502 |
Neurology
|
Alzheimer Disease |
M 1
|
D
|
| 466 | M1.RP.14.27 | 107013 |
Reproductive
|
Klinefelter Syndrome |
M 1
|
D
|
| 467 | M1.PY.16.4681 | 107293 |
Psychiatry
|
Schizophrenia |
M 2
|
D
|
| 468 | M1.CV.13.90 | 100606 |
Cardiovascular
|
Antihypertensive Therapy |
M 4
|
D
|
| 469 | M1.CV.13.112 | 100628 |
Cardiovascular
|
Rheumatic Heart Disease |
M 2
|
D
|
| 470 | M1.EC.14.34 | 100335 |
Endocrine
|
Adrenogenital Syndrome (Congenital Adrenal Hyperplasia) |
M 2
|
D
|
| 471 | M1.MK.14.2 | 100423 |
MSK
|
Systemic Lupus Erythematosus |
M 2
|
D
|
| 472 | M1.MC.13.104 | 101563 |
Microbiology
|
Staphylococcus aureus |
M 1
|
D
|
| 473 | M1.RP.13.1 | 101663 |
Reproductive
|
Klinefelter Syndrome |
M 2
|
D
|
| 474 | M1.NE.14.34 | 101698 |
Neurology
|
Meningitis |
M 2
|
D
|
| 475 | M1.ON.14.26 | 103819 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
D
|
| 476 | M1.MK.13.35 | 100456 |
MSK
|
Systemic Lupus Erythematosus |
M 2
|
D
|
| 477 | M1.EC.13.28 | 100329 |
Endocrine
|
Adrenogenital Syndrome (Congenital Adrenal Hyperplasia) |
M 2
|
D
|
| 478 | M1.MK.12.3 | 101940 |
MSK
|
Scleroderma |
M 2
|
D
|
| 479 | M1.MK.14.28 | 101965 |
MSK
|
Rickets / Osteomalacia |
M 1
|
D
|
| 480 | M1.PH.14.44 | 100847 |
Pharmacology
|
Beta-Blockers |
M 3
|
D
|
| 481 | M1.HE.14.131 | 104771 |
Hematology
|
Thalassemia Anemia |
M 3
|
D
|
| 482 | M1.EC.13.14 | 101951 |
Endocrine
|
Hyperparathyroidism |
M 1
|
D
|
| 483 | M1.MK.12.65 | 102002 |
MSK
|
Polymyositis / Dermatomyositis |
M 2
|
D
|
| 484 | M1.ON.16.4753 | 108770 |
Oncology
|
Acute Myelogenous Leukemia (AML) |
M 2
|
D
|
| 485 | M1.PY.13.40 | 100040 |
Psychiatry
|
Depression |
M 2
|
D
|
| 486 | M1.MK.14.41 | 106264 |
MSK
|
Osteoarthritis |
M 2
|
D
|
| 487 | M1.EC.14.80 | 100381 |
Endocrine
|
Hyperaldosteronism / Conn Syndrome |
M 2
|
D
|
| 488 | M1.RL.13.56 | 101010 |
Renal
|
Chronic Kidney Disease (CKD) |
M 2
|
D
|
| 489 | M1.RL.13.12 | 100966 |
Renal
|
Chronic Kidney Disease (CKD) |
M 2
|
D
|
| 490 | M1.NE.14.27 | 101691 |
Neurology
|
Cerebrospinal Fluid (CSF) |
M 2
|
D
|
| 491 | M1.RL.14.62 | 101016 |
Renal
|
Renal Clearance |
M 1
|
D
|
| 492 | M1.EB.16.4753 | 108885 |
Embryology
|
Genital Embryology |
M 2
|
D
|
| 493 | M1.MC.14.157 | 101616 |
Microbiology
|
Streptococcus pyogenes (Group A Streptococci) |
M 1
|
D
|
| 494 | M1.ON.13.29 | 101693 |
Oncology
|
Acute Lymphoblastic Leukemia (ALL) |
M 1
|
D
|
| 495 | M1.PY.16.73 | 106596 |
Psychiatry
|
Depression |
M 2
|
D
|
| 496 | M1.MC.13.139 | 101598 |
Microbiology
|
Parvovirus B19 |
M 2
|
D
|
| 497 | M1.GI.14.5 | 103798 |
Gastrointestinal
|
Celiac Disease |
M 2
|
D
|
| 498 | M1.GI.14.49 | 106323 |
Gastrointestinal
|
Celiac Disease |
M 2
|
D
|
| 499 | M1.EC.14.0 | 106982 |
Endocrine
|
Congenital Hypothyroidism (Cretinism) |
M 2
|
D
|
| 500 | M1.MC.14.1 | 106432 |
Microbiology
|
Babesia |
M 2
|
D
|
| 501 | M1.ON.13.1 | 101662 |
Oncology
|
Malignant Breast Tumors |
M 2
|
D
|
| 502 | M1.BC.15.73 | 106554 |
Biochemistry
|
Modes of Inheritance |
M 1
|
D
|
| 503 | M1.MC.14.1 | 106314 |
Microbiology
|
Clostridium tetani |
M 1
|
D
|
| 504 | M1.PH.13.89 | 100605 |
Pharmacology
|
Pharmacokinetics |
M 1
|
D
|
| 505 | M1.MC.13.152 | 101611 |
Microbiology
|
Streptococcus pyogenes (Group A Streptococci) |
M 1
|
D
|
| 506 | M1.BC.15.1 | 106971 |
Biochemistry
|
Modes of Inheritance |
M 1
|
D
|
| 507 | M1.RL.16.4718 | 108497 |
Renal
|
Renal Cyst Disorders |
M 1
|
D
|
| 508 | M1.BC.15.17 | 107083 |
Biochemistry
|
Lysosome |
M 1
|
D
|
| 509 | M1.MC.16.4722 | 108551 |
Microbiology
|
Parvovirus B19 |
M 1
|
D
|
| 510 | M1.BC.15.74 | 106626 |
Biochemistry
|
Lysosome |
M 2
|
D
|
| 511 | M1.EC.13.14 | 101908 |
Endocrine
|
Gestational Diabetes |
M 2
|
D
|
| 512 | M1.EC.16.4707 | 108451 |
Endocrine
|
Hypoparathyroidism |
M 2
|
D
|
| 513 | M1.PY.16.4699 | 108384 |
Psychiatry
|
Alcohol Withdrawal |
M 2
|
D
|
| 514 | M1.EC.13.65 | 100366 |
Endocrine
|
Diabetes Insipidus |
M 2
|
D
|
| 515 | M1.NE.16.4671 | 107134 |
Neurology
|
Hypothalamus |
M 1
|
D
|
| 516 | M1.NE.16.4671 | 107136 |
Neurology
|
Hypothalamus |
M 1
|
D
|
| 517 | M1.GI.16.4695 | 107963 |
Gastrointestinal
|
Cholelithiasis |
M 1
|
D
|
| 518 | M1.CV.13.47 | 100468 |
Cardiovascular
|
Small Vessel Vasculitides with Immune Complexes |
M 1
|
D
|
| 519 | M1.ST.16.4686 | 107409 |
Stats
|
Disease Prevention |
M 4
|
D
|
| 520 | M1.PY.13.49 | 101713 |
Psychiatry
|
Buspirone |
M 3
|
D
|
| 521 | M1.EC.14.70 | 106482 |
Endocrine
|
Adrenal Cortex and Medulla |
M 1
|
D
|
| 522 | M1.MC.14.5 | 105005 |
Microbiology
|
Aminoglycosides |
M 1
|
D
|
| 523 | M1.RL.13.9 | 104283 |
Renal
|
Acid-Base Disorders |
M 1
|
D
|
| 524 | M1.GI.16.4697 | 108129 |
Gastrointestinal
|
Primary Biliary Cholangitis |
M 2
|
D
|
| 525 | M1.CV.16.4686 | 107386 |
Cardiovascular
|
Endocarditis |
M 2
|
D
|
| 526 | M1.ON.16.4699 | 108402 |
Oncology
|
Prostate Cancer |
M 2
|
D
|
| 527 | M1.BC.14.71 | 106499 |
Biochemistry
|
Karyotyping |
M 2
|
D
|
| 528 | M1.ON.14.6 | 101063 |
Oncology
|
Esophageal Cancer |
M 2
|
D
|
| 529 | M1.NE.14.75 | 106875 |
Neurology
|
Cavernous Sinuses |
M 1
|
D
|
| 530 | M1.NE.14.77 | 106877 |
Neurology
|
Brainstem |
M 1
|
D
|
| 531 | M1.NE.14.11 | 101675 |
Neurology
|
Brainstem |
M 1
|
D
|
| 532 | M1.EC.16.4695 | 107934 |
Endocrine
|
Diabetes Insipidus |
M 1
|
D
|
| 533 | M1.ST.16.4738 | 108642 |
Stats
|
Leading Causes of Death in the US |
M 1
|
D
|
| 534 | M1.PL.13.31 | 100834 |
Respiratory
|
Pulmonary Hypertension Drugs |
M 3
|
D
|
| 535 | M1.MK.14.201 | 106235 |
MSK
|
TNF-alpha Inhibitors |
M 1
|
D
|
| 536 | M1.GI.14.72 | 101129 |
Gastrointestinal
|
Whipple Disease |
M 2
|
D
|
| 537 | M1.MK.14.29 | 103822 |
Dermatology
|
Actinic Keratosis |
M 2
|
D
|
| 538 | M1.MC.14.66 | 104513 |
Microbiology
|
Hepatitis C Virus |
M 2
|
D
|
| 539 | M1.MC.14.78 | 106887 |
Microbiology
|
Gram-Positive Bacteria |
M 1
|
D
|
| 540 | M1.CV.13.54 | 100570 |
Cardiovascular
|
Capillary Fluid Exchange |
M 1
|
D
|
| 541 | M1.CV.15.75 | 106815 |
Cardiovascular
|
Myocardial Infarction |
M 1
|
D
|
| 542 | M1.MC.14.44 | 105442 |
Microbiology
|
Intracellular Organisms |
M 3
|
D
|
| 543 | M1.HE.14.59 | 100124 |
Hematology
|
Methemoglobinemia |
M 3
|
D
|
| 544 | M1.RP.14.24 | 105422 |
Reproductive
|
Gynecomastia |
M 3
|
D
|
| 545 | M1.EC.16.4707 | 108453 |
Endocrine
|
Adrenal Cortex and Medulla |
M 1
|
D
|
| 546 | M1.ON.13.7 | 103800 |
Oncology
|
Angiosarcoma |
M 2
|
D
|
| 547 | M1.ST.15.19 | 102598 |
Stats
|
Statistical Distribution |
M 1
|
D
|
| 548 | M1.GI.13.68 | 101125 |
Gastrointestinal
|
Pancreatic Pseudocysts |
M 2
|
D
|
| 549 | M1.GI.16.4698 | 108245 |
Gastrointestinal
|
Gilbert Syndrome |
M 2
|
D
|
| 550 | M1.MC.16.4699 | 108357 |
Microbiology
|
Flukes (Trematodes) |
M 2
|
D
|
| 551 | M1.MC.16.4695 | 108050 |
Microbiology
|
Rubeola (Measles) |
M 2
|
D
|
| 552 | M1.NE.16.4720 | 108511 |
Neurology
|
Glaucoma |
M 2
|
D
|
| 553 | M1.PL.16.49 | 100852 |
Respiratory
|
Fat Embolus Syndrome |
M 1
|
D
|
| 554 | M1.PY.16.4699 | 108385 |
Psychiatry
|
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) |
M 3
|
D
|
| 555 | M1.PY.16.4754 | 108908 |
Psychiatry
|
Phobic Disorders |
M 3
|
D
|
| 556 | M1.PY.16.4754 | 108913 |
Psychiatry
|
Learning and Conditioning |
M 2
|
D
|
| 557 | M1.MC.16.4699 | 108342 |
Microbiology
|
Aztreonam |
M 3
|
D
|
| 558 | M1.MC.16.4699 | 108352 |
Microbiology
|
Bacillus cereus |
M 2
|
D
|
| 559 | M1.RP.16.4753 | 108899 |
Reproductive
|
Menopause |
M 2
|
D
|
| 560 | M1.HE.16.4698 | 108269 |
Hematology
|
Disseminated Intravascular Coagulation (DIC) |
M 2
|
D
|
| 561 | M1.ST.15.73 | 106577 |
Stats
|
Ethical Principles |
M 2
|
D
|
| 562 | M1.RP.16.4753 | 108900 |
Reproductive
|
Kallmann Syndrome |
M 1
|
D
|
| 563 | M1.EC.15.1 | 107077 |
Endocrine
|
Diabetes Drugs |
M 1
|
D
|
| 564 | M1.ST.15.73 | 106585 |
Stats
|
Ethical Principles |
M 3
|
D
|
| 565 | M1.ST.15.44 | 102798 |
Stats
|
Ethical Principles |
M 4
|
D
|
| 566 | M1.ST.15.78 | 105748 |
Stats
|
Ethical Principles |
M 4
|
D
|
| 567 | M1.ST.15.73 | 106570 |
Stats
|
Ethical Principles |
M 3
|
D
|
| 568 | M1.HE.16.4699 | 108327 |
Hematology
|
Thrombolytics |
M 3
|
D
|
| 569 | M1.CV.14.144 | 100660 |
Cardiovascular
|
Congestive Heart Failure |
M 1
|
D
|
| 570 | M1.BC.14.2 | 102720 |
Biochemistry
|
Modes of Inheritance |
M 1
|
D
|
| 571 | M1.BC.14.1 | 106276 |
Biochemistry
|
Lysosome |
M 1
|
D
|
| 572 | M1.BC.14.27 | 107008 |
Biochemistry
|
Lysosome |
M 2
|
D
|
| 573 | M1.ST.15.24 | 104030 |
Stats
|
Bias |
M 1
|
D
|
| 574 | M1.BC.15.72 | 106501 |
Biochemistry
|
Amino Acid Catabolism |
M 2
|
D
|
| 575 | M1.BC.15.74 | 106628 |
Biochemistry
|
Amino Acid Catabolism |
M 1
|
D
|
| 576 | M1.HE.15.74 | 106614 |
Hematology
|
Sickle Cell Anemia |
M 1
|
D
|
| 577 | M1.PH.15.75 | 106842 |
Pharmacology
|
Poisons and Treatments |
M 3
|
D
|
| 578 | M1.RL.15.43 | 100997 |
Renal
|
Nephritic Syndrome |
M 2
|
D
|
| 579 | M1.PY.15.27 | 107045 |
Psychiatry
|
Ego Defenses |
M 2
|
D
|
| 580 | M1.MC.15.4669 | 107122 |
Microbiology
|
Opportunistic Mycoses |
M 2
|
D
|
| 581 | M1.MC.15.75 | 106703 |
Microbiology
|
Opportunistic Mycoses |
M 2
|
D
|
| 582 | M1.RL.15.4671 | 107161 |
Renal
|
Urinary Tract Infection |
M 2
|
D
|
| 583 | M1.BC.15.72 | 106536 |
Biochemistry
|
Chromosomal Diseases |
M 1
|
D
|
| 584 | M1.BC.15.73 | 106545 |
Biochemistry
|
Chromosomal Diseases |
M 1
|
D
|
| 585 | M1.BC.15.72 | 106508 |
Biochemistry
|
Chromosomal Diseases |
M 2
|
D
|
| 586 | M1.BC.15.73 | 106541 |
Biochemistry
|
Chromosomal Diseases |
M 2
|
D
|
| 587 | M1.PL.14.0 | 106978 |
Respiratory
|
Cystic Fibrosis |
M 1
|
D
|
| 588 | M1.EB.15.26 | 101048 |
Embryology
|
GI Embryology |
M 1
|
D
|
| 589 | M1.PL.14.91 | 104731 |
Respiratory
|
Cystic Fibrosis |
M 4
|
D
|
| 590 | M1.CV.15.74 | 106606 |
Cardiovascular
|
Antianginal Therapy |
M 3
|
D
|
| 591 | M1.CV.15.4196 | 106996 |
Cardiovascular
|
Antianginal Therapy |
M 3
|
D
|
| 592 | M1.IM.15.75 | 100496 |
Immunology
|
Bruton Agammaglobulinemia |
M 1
|
D
|
| 593 | M1.ST.14.71 | 103888 |
Stats
|
Statistical Measures |
M 1
|
D
|
| 594 | M1.RL.15.4671 | 107147 |
Renal
|
Nephrolithiasis |
M 2
|
D
|
| 595 | M1.PL.15.118 | 100921 |
Respiratory
|
Pneumoconioses |
M 2
|
D
|
| 596 | M1.PY.15.27 | 107032 |
Psychiatry
|
Signs and Symptoms of Drug Abuse (by Drug) |
M 2
|
D
|
| 597 | M1.PH.15.1 | 107079 |
Pharmacology
|
Sympathomimetics |
M 1
|
D
|
| 598 | M1.ST.13.3 | 103366 |
Stats
|
Ethical Principles |
M 1
|
D
|
| 599 | M1.HE.15.4666 | 107106 |
Hematology
|
Anticoagulants |
M 3
|
D
|
| 600 | M1.ST.13.6 | 100006 |
Stats
|
Ethical Principles |
M 4
|
D
|